THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1

被引：315
作者：
COLOTTA, F
DOWER, SK
SIMS, JE
MANTOVANI, A
机构：
[1] UNIV BRESCIA,DEPT BIOTECHNOL,PATHOL SECT,I-25123 BRESCIA,ITALY
[2] IMMUNEX RES & DEV CORP,SEATTLE,WA 98101
来源：
IMMUNOLOGY TODAY | 1994年 / 15卷 / 12期
关键词：
D O I：
10.1016/0167-5699(94)90217-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The interleukin 1 (IL-1) system plays a central role in inflammation and immunity. Of the two receptors that bind IL-1, the type I receptor is known to mediate signaling activity: whereas the function of the type II receptor remains unknown. Here, Francesco Colotta and colleagues review the properties of these receptors and summarize evidence indicating that the type II receptor acts as a regulated decoy target for IL-1.
引用
收藏
页码：562 / 566
页数：5
相关论文
共 50 条
[21]   A CHIMERIC TYPE-II/TYPE-I INTERLEUKIN-1 RECEPTOR CAN MEDIATE INTERLEUKIN-1 INDUCTION OF GENE-EXPRESSION IN T-CELLS [J].
HEGUY, A ;
BALDARI, CT ;
CENSINI, S ;
GHIARA, P ;
TELFORD, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (14) :10490-10494
[22]   Negative regulators of the interleukin-1 system: Receptor antagonists and a decoy receptor [J].
Mantovani, A ;
Muzio, M ;
Ghezzi, P ;
Colotta, F ;
Introna, M .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1996, 26 (01) :7-14
[23]   The decoy receptor interleukin-1 receptor type 2 acts as an angiogenic factor in human colorectal cancer [J].
Mar, Ai-Chung .
CANCER RESEARCH, 2015, 75
[24]   Role of interleukin-1 receptor type II in the pathogenesis of endometriosis [J].
Hou, Zhen ;
Zhou, Jing ;
Ma, Xiang ;
Fan, Lu ;
Liu, Jiayin .
PROGRESS ON POST-GENOME TECHNOLOGIES, 2007, :427-428
[25]   Effect of interleukin-1 receptor type II in the pathogenesis of endometriosis [J].
Hou, Z. ;
Zhou, J. ;
Liu, J. .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2006, 71 (02) :162-162
[26]   Role of interleukin-1 receptor type II in the pathogenesis of endometriosis [J].
Hou, Zhen ;
Zhou, Jing ;
Ma, Xiang ;
Fan, Lu ;
Liao, Lianming ;
Liu, Jiayin .
FERTILITY AND STERILITY, 2008, 89 (01) :42-51
[27]   The novel vaccines targeting interleukin-1 receptor type I [J].
Zhou, Yanzhao ;
Huang, Jianwu ;
Mai, Wuqian ;
Kuang, Wenlong ;
Li, Xin ;
Shi, Dingyang ;
Yang, Yulu ;
Wu, Jiacheng ;
Wu, Zhijie ;
Liao, Yuhua ;
Zhou, Zihua ;
Qiu, Zhihua .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 132
[28]   Expression of the decoy type 2 interleukin-1 receptor in mouse and its putative role in inflammation [J].
Martin, P. ;
Palmer, G. ;
Vigne, S. ;
Lamacchia, C. ;
Strebel, D. ;
Rodriguez, E. ;
Talabot-Ayer, D. ;
Gabay, C. .
CYTOKINE, 2012, 59 (03) :513-513
[29]   INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
ESPAT, NJ ;
ROGY, MA ;
COPELAND, EM ;
MOLDAWER, LL .
PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) :393-400
[30]   HUMAN AORTIC ENDOTHELIAL-CELLS EXPRESS THE TYPE-I BUT NOT THE TYPE-II RECEPTOR FOR INTERLEUKIN-1 (IL-1) [J].
AKESON, AL ;
MOSHER, LB ;
WOODS, CW ;
SCHROEDER, KK ;
BOWLIN, TL .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (03) :583-588
12345